Australian Clinical Labs Limited provides pathology diagnostic services in Australia. The company offers range of services, including molecular cancer, harmony NIPT, genetic carrier screening and other antenatal, cardiac, and commercial drug and alcohol testing services; chemical pathology, haematology, histopathology and cytopathology, serology and microbiology, allergy and immunology, and veterinary and functional pathology services; pathology services for clinical trials; and CPD programs. It serves doctors, patients, and corporate clients. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Metrics to compare | ACL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACLPeersSector | |
---|---|---|---|---|
P/E Ratio | 16.8x | 23.9x | −0.6x | |
PEG Ratio | 0.40 | −0.02 | 0.00 | |
Price/Book | 3.2x | 1.7x | 2.6x | |
Price / LTM Sales | 0.7x | 1.2x | 3.3x | |
Upside (Analyst Target) | 25.0% | 15.6% | 39.1% | |
Fair Value Upside | Unlock | 21.5% | 5.4% | Unlock |